2Neil K, Berkelman R. Increasing incidence of legionellosis in the United States, 1990-2005: changing epidemiologic trends [ J ]. Clin infect dis,2008,47:591 -599.
3Pagnier I, Merchat M, La Scola B. Potentially pathogenic amoeba- associated microorganisms in cooling towers and their control[ J ]. Future Microbio1,2009 ,4 :615 - 629.
4Jespersen S, Sogaard OS, Schonheyder HC, et al. Clinical featuresand predictors of mortality in admitted patients with community- and hospital-acquired legionellosis:a Danish historical cohort study [ J]. BMC Infect Dis ,2010,10 : 124.
5Greenberg D, Chiou CC, Famigilleti R, et al. Problem pathogens: paediatric legionellosis - implications for improved diagnosis [ J ]. Lancet Infect Dis,2006,6:529 - 535.
6Shimada T, Noguchi Y, Jackson JL, et al. Systematic review and metaanalysis: urinary antigen tests for Legionellosis [ J ]. Chest, 2009,136 : 1576 - 1585.
7Diederen BM, Kluytmans JA, Vandenbroucke-Grauls CM, el al. U- tility of real-time PCR for diagnosis of Legionnaires' disease in rou- tine clinical practice [ J ]. J Clin Microbiol, 2008,46:671 - 677.
8Stout JE, Sens K, Mietzner S, et al. Comparative activity of quinolo- nes,macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing[ J]. Int J Antimicrob Agents ,2005,25:302 -307.
9Dubois J, St-Pierre C. In vitro activity, postantibiotie effect and human monoeyte activity of grepafloxaein against Legionella spe- cies[ J]. Clin mierobiol and infect, 1.999,5:205 - 212.
10Takakuwa O, Yamamoto T, Kawai A, et al. Successful treatment of Legionena pneumonia with moxifloxaein in a hemodialysis patien.t [ J]. Nihon Kokyuki Gakkai zasshi ,2009,47:625 -630.
